Amplia Therapeutics Ltd.ASX: ATX

Phase 2 Trial in First-Line Pancreatic Cancer Patients

Sep 15, 2021 at 3:31 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment